Am J Transplant, Volume 20, Suppl 3 Archives - Page 11 of 223 - ATC Abstracts

2020 American Transplant Congress
Is it Safe to Use Organs from Deceased Donor with Open Abdomen?
G. El-Gazzaz, A. L. Friedman
Live On New York, New York, NY
*Purpose: The shortage of organs supplies and increased number of waiting patients for organs transplantation allowed to review historical contraindication for donation. Due to limited…
2020 American Transplant Congress
Long Term Outcome of Patients Transplanted for Non Alcoholic Steatohepatitis Related Cirrhosis
W. Alhamoudi¹, I. Salih², S. Yousif², M. Shawkat³, K. Bzeizi², S. Alghamdi², A. Albenmousa², D. Broering²
¹Medicine, King Saud University, Riyadh, Saudi Arabia, ²Liver Transplant, King Faisal Specialist Hospital, Riyadh, Saudi Arabia, ³Internal Medicine, Minia University, Minia, Egypt
*Purpose: Nonalcoholic fatty liver disease (NAFLD) has emerged as the most common chronic liver disease worldwide. Cirrhosis secondary to Nonalcoholic Steatohepatitis (NASH) is projected to…
2020 American Transplant Congress
Validation of the Model for End-Stage Liver Disease Sodium Score in the Eurotransplant Region
B. F. Goudsmit¹, H. Putter², B. Van Hoek³, A. E. Braat¹
¹Transplantation Surgery, Leiden University Medical Center, Leiden, Netherlands, ²Biostatistics, Leiden University Medical Center, Leiden, Netherlands, ³Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, Netherlands
*Purpose: The shortage of liver grafts results in the prioritization of the sickest patients on the waiting list for liver transplantation. Since 2006, the degree…
2020 American Transplant Congress
The Strategy and Utility of Checkpoint Inhibitor Therapy in Patient with Hepatocellular Carcinoma Recurrence Following Liver Transplantation
L. Jeng, S. Hsu, A. Thorat
China Medical University Hospital, Taichung, Taiwan
*Purpose: Checkpoint inhibitor therapy is a hot and rapidly progressive therapy in advanced cancer patients in the past 2 years. Although some successful case report…
2020 American Transplant Congress
Development of Novel Multivariable Logistic Regression Model for Predicting Graft Failure within 2 Weeks and 4 Weeks after Liver Transplantation Using Post-Transplantation Laboratory Values
J. Kwon, S. Kim, G. Choi, J. Joh, J. Park, J. Rhu, K. Kim, O. Lee, M. Lim, E. Jeong, J. Yang
Transplantation, Samsung Medical Center, Seoul, Korea, Republic of
*Purpose: This study designed a prediction model for graft failure after liver transplantation.*Methods: Multivariable logistic regression including aspartate aminotransferase (AST), total bilirubin (TB), and international…
2020 American Transplant Congress
Early Post-Transplant Infection after Kidney Transplantation in Korea: Incidence, Risk Factors and Clinical Impact
R. Ra, S. Kang, J. Kim, H. Hwang, Y. Kim, J. Moon, S. Lee, S. Jung, K. Jeong
Kyung Hee University School of Medicine, Seoul, Korea, Republic of
*Purpose: Post-transplant infection is a frequent and devastating complication after kidney transplantation (KT). Since the characteristics of post-transplant infection have changed over time after KT…
2020 American Transplant Congress
Cryptococcosis In Kidney Transplant Recipients: A Multicenter Retrospective Case-Control Study
L. Tardieu¹, O. Lortholary², F. Lanternier², A. Scemla³, C. Rafat¹
¹Urgences Néphrologiques et Transplantation Rénale, Hôpital Tenon, APHP, Paris, France, ²Service de Maladies Infectieuses et Tropicales – Centre d’Infectiologie Necker-Pasteur, Hôpital Necker, APHP, Paris, France, ³Service de Transplantation Rénale, Hôpital Necker, APHP, Paris, France
*Purpose: Cryptococcosis is the third most common invasive fungal infection in organ transplant recipients.The clinical approach and prognosis has been previously investigated in the setting…
2020 American Transplant Congress
Fibrosing Cholestatic Hepatatitis in Post Renal Transplant and Successful Treatment with Newer DAA Therapy
V. Siddini
Nephrology, Manipal Hospital, Bangalore, India
*Purpose: Fibrosing cholestatic hepatitis is often fatal post renal transplantation. we report a case of successful treatment of FCH and complete recovery*Methods: A 53 year…
2020 American Transplant Congress
Maximizing the Gift: One OPO’s Experience Maximizing the Gift of Organ Donation by Successfully Increasing the Number of Organs Transplanted from Non-Braindead Donors
J. B. Nave, A. J. Boyer, C. A. Hostetler, C. C. Muse, R. A. Squires, J. P. Orlowski
LifeShare Transplant Donor Services of Oklahoma, Oklahoma City, OK
*Purpose: In 2018 in the United States, donation after circulatory death (DCD) cases accounted for 20% of deceased organ donor recoveries1. Our organ procurement organization's…
2020 American Transplant Congress
Development of Recommendations for Liver Transplant Anesthesia Teams Using a Modified Delphi Process
C. Crouch, A. Hendrickse, S. Mandell
Department of Anesthesiology, University of Colorado, Aurora, CO
*Purpose: We utilized a modified Delphi technique to develop recommendations to guide service responsibilities for liver transplant anesthesia teams (LTATs).*Methods: The Society for the Advancement…